Skip to main content
Log in

Consider adjusting the dose of antibacterials in critically ill patients with hypoalbuminaemia

  • Practical Issues and Updates
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Table I
Table II

References

  1. Ulldemolins M, Roberts JA, Rello J, et al. The effects of hypoalbuminaemia on optimizing antibacterial dosing in critically ill patients. Clin Pharmacokinet 2011; 50(2): 99–110

    Article  PubMed  CAS  Google Scholar 

  2. Roberts JA, Lipman J. Antibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis. Clin Pharmacokinet 2006; 45(8): 755–73

    Article  PubMed  CAS  Google Scholar 

  3. Roberts JA, Lipman J. Pharmacokinetic issues for antibiotics in the critically ill patient. Crit Care Med 2009; 37(3): 840–51

    Article  PubMed  CAS  Google Scholar 

  4. Finfer S, Bellomo R, McEvoy S, et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the Saline versus Albumin Fluid Evaluation (SAFE) study. BMJ 2006; 333(7577): 1044

    Article  PubMed  CAS  Google Scholar 

  5. Tillement JP, Lhoste F, Giudicelli JF. Diseases and drug protein binding. Clin Pharmacokinet 1978; 3(2): 144–54

    Article  PubMed  CAS  Google Scholar 

  6. Merrikin DJ, Briant J, Rolinson GN. Effect of protein binding on antibiotic activity in vivo. J Antimicrob Chemother 1983; 11(3): 233–8

    Article  PubMed  CAS  Google Scholar 

  7. Liu P, Derendorf H. Antimicrobial tissue concentrations. Infect Dis Clin North Am 2003; 17(3): 599–613

    Article  PubMed  Google Scholar 

  8. Goldstein A. The interactions of drugs and plasma proteins. J Pharmacol Exp Ther 1949; 95 Pt 2 (4): 102–65

    PubMed  CAS  Google Scholar 

  9. Joynt GM, Lipman J, Gomersall D, et al. The pharmacokinetics of once-daily dosing of ceftriaxone in critically ill patients. J Antimicrob Chemother 2001; 47(4): 421–9

    Article  PubMed  CAS  Google Scholar 

  10. Burkhardt O, Kumar V, Katterwe D, et al. Ertapenem in critically ill patients with early-onset ventilator-associated pneumonia: pharmacokinetics with special consideration of free-drug concentration. J Antimicrob Chemother 2007; 59(2): 277–84

    Article  PubMed  CAS  Google Scholar 

  11. Brink AJ, Richards GA, Schillack V, et al. Pharmacokinetics of once-daily dosing of ertapenem in critically ill patients with severe sepsis. Int J Antimicrob Agents 2009; 33(5): 432–6

    Article  PubMed  CAS  Google Scholar 

  12. Janicke DM, Cafarell RF, Parker SW, et al. Pharmacokinetics of aztreonam in patients with Gram-negative infections. Antimicrob Agents Chemother 1985; 27(1): 16–20

    Article  PubMed  CAS  Google Scholar 

  13. Friedrich LV, White RL, Kays MB, et al. Aztreonam pharmacokinetics in burn patients. Antimicrob Agents Chemother 1991; 35(1): 57–61

    Article  PubMed  CAS  Google Scholar 

  14. Peter JD, Jehl F, Pottecher T, et al. Pharmacokinetics of intravenous fusidic acid in patients with cholestasis. Antimicrob Agents Chemother 1993; 37(3): 501–6

    Article  PubMed  CAS  Google Scholar 

  15. MacGowan AP. Pharmacodynamics, pharmacokinetics, and therapeutic drug monitoring of glycopeptides. Ther Drug Monit 1998; 20(5): 473–7

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Consider adjusting the dose of antibacterials in critically ill patients with hypoalbuminaemia. Drugs Ther. Perspect 27, 23–25 (2011). https://doi.org/10.2165/11208040-000000000-00000

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/11208040-000000000-00000

Navigation